Bioneer Corporation (KOSDAQ:064550)
South Korea · Delayed Price · Currency is KRW 10,440
+280 (2.76%)
Apr 10, 2026, 3:30 PM KST
Bioneer Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 330,111 | 293,975 | 263,237 | 218,394 | 223,744 |
Other Revenue | - | -0 | - | -0 | -0 |
| 330,111 | 293,975 | 263,237 | 218,394 | 223,744 | |
Revenue Growth (YoY) | 12.29% | 11.68% | 20.53% | -2.39% | 8.09% |
Cost of Revenue | 73,316 | 74,487 | 60,737 | 52,323 | 50,528 |
Gross Profit | 256,794 | 219,489 | 202,500 | 166,072 | 173,216 |
Selling, General & Admin | 223,946 | 206,275 | 181,642 | 131,670 | 106,632 |
Research & Development | 12,806 | 19,174 | 15,031 | 16,751 | 17,987 |
Amortization of Goodwill & Intangibles | 959.45 | 1,077 | 850.85 | 800.4 | 617.63 |
Other Operating Expenses | 1,352 | 1,218 | 1,195 | 1,121 | 848.41 |
Operating Expenses | 241,569 | 232,904 | 201,727 | 155,328 | 126,150 |
Operating Income | 15,225 | -13,415 | 772.7 | 10,744 | 47,066 |
Interest Expense | -4,615 | -3,418 | -1,408 | -647.92 | -641.36 |
Interest & Investment Income | 1,861 | 1,629 | 1,304 | 539.29 | 36.88 |
Currency Exchange Gain (Loss) | -149.77 | 1,120 | 76.44 | 512.83 | 1,108 |
Other Non Operating Income (Expenses) | -1,605 | -337.02 | -356.22 | 774.52 | -7,771 |
EBT Excluding Unusual Items | 10,717 | -14,421 | 389.73 | 11,923 | 39,799 |
Gain (Loss) on Sale of Investments | -800.12 | -792.53 | -494.46 | 1,922 | 2,599 |
Gain (Loss) on Sale of Assets | -14.87 | 37.75 | 2.56 | 16.81 | 834.55 |
Asset Writedown | - | -148.96 | - | - | - |
Other Unusual Items | - | - | 35.17 | 42.69 | 44.8 |
Pretax Income | 9,902 | -15,325 | -67 | 13,904 | 43,278 |
Income Tax Expense | 8,195 | 3,717 | 6,852 | -1,218 | 14,079 |
Earnings From Continuing Operations | 1,707 | -19,042 | -6,919 | 15,122 | 29,199 |
Minority Interest in Earnings | -4,520 | -1,542 | -3,668 | -3,045 | -2,039 |
Net Income | -2,813 | -20,584 | -10,587 | 12,077 | 27,160 |
Net Income to Common | -2,813 | -20,584 | -10,587 | 12,077 | 27,160 |
Net Income Growth | - | - | - | -55.53% | -53.09% |
Shares Outstanding (Basic) | 26 | 26 | 26 | 26 | 25 |
Shares Outstanding (Diluted) | 26 | 26 | 26 | 26 | 25 |
Shares Change (YoY) | 0.05% | -0.06% | - | 2.00% | 2.99% |
EPS (Basic) | -109.00 | -798.00 | -410.19 | 467.91 | 1073.38 |
EPS (Diluted) | -109.00 | -798.00 | -410.19 | 467.91 | 1073.00 |
EPS Growth | - | - | - | -56.39% | -55.40% |
Free Cash Flow | -37,679 | -26,111 | -523.93 | -8,655 | 10,998 |
Free Cash Flow Per Share | -1459.94 | -1012.27 | -20.30 | -335.31 | 434.64 |
Gross Margin | 77.79% | 74.66% | 76.93% | 76.04% | 77.42% |
Operating Margin | 4.61% | -4.56% | 0.29% | 4.92% | 21.04% |
Profit Margin | -0.85% | -7.00% | -4.02% | 5.53% | 12.14% |
Free Cash Flow Margin | -11.41% | -8.88% | -0.20% | -3.96% | 4.92% |
EBITDA | 24,193 | -4,287 | 9,726 | 18,814 | 52,921 |
EBITDA Margin | 7.33% | -1.46% | 3.69% | 8.62% | 23.65% |
D&A For EBITDA | 8,968 | 9,128 | 8,953 | 8,069 | 5,855 |
EBIT | 15,225 | -13,415 | 772.7 | 10,744 | 47,066 |
EBIT Margin | 4.61% | -4.56% | 0.29% | 4.92% | 21.04% |
Effective Tax Rate | 82.76% | - | - | - | 32.53% |
Advertising Expenses | 48,707 | 45,717 | 37,620 | 25,962 | 14,326 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.